Torno Capital’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,000
Closed -$23.4K 99
2025
Q3
$23.4K Buy
+15,000
New +$22.4K ﹤0.01% 76

Torno Capital's LVTX Position: Q4 2025 in Review

Torno Capital sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 15,000 shares — an estimated $23.4K sold.

Torno Capital first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $23.4K in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

  • Torno Capital reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Torno Capital sold 15,000 LAVA Therapeutics shares in Q4 2025, an estimated $23.4K.
  • Torno Capital first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
  • Torno Capital's LAVA Therapeutics position peaked at $23.4K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on Torno Capital's 13F filing for Q4 2025, filed 17 Feb 2026.